Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Health Catalyst, Inc. (NASDAQ: HCAT)
HCAT Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-11.30%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-7.90%
HCAT Stock Analysis
HCAT
PE Ratio:
HCAT
PEG Ratio:
HCAT
Forward EPS Growth (12 month):
92.50%
HCAT
PS Ratio:
0.3
HCAT
PSG Ratio:
-0.1
HCAT
Forward Revenue Growth (12 month):
-6.10%
HCAT Articles
No data was found